processing...

Dr. Amit Jain

Dr. Amit Jain
M.B.B.S, MD - Radiotherapy

Dr. Amit Jain

Department: Oncology (Cancer Care)
Work experience: 19 Years
Consultation Fees: Rs 1200
Location: Delhi

Expert in specialities:

Renowned for transforming lives through precision and compassionate care, Dr. Amit Jain, the best radiation oncologist in Delhi, brings a wealth of expertise garnered from a stellar academic journey – from earning his M.B.B.S. at Dr. V.M. Medical College to achieving mastery in Clinical Oncology at Tata Memorial Hospital. With a proven track record as a Consultant Radiation Oncologist at SMH-Curie Cancer Centre, Delhi, and later as the Head of Radiation Oncology at Valentis Cancer Hospital, Meerut, Dr. Jain stands as a beacon of excellence. His groundbreaking research at Tata Memorial Hospital and Nanavati Hospital, along with international training in high-precision radiation therapy techniques, underscores his commitment to advancing cancer care. Embrace quality healthcare with Dr. Amit Jain, where expertise meets empathy, defining a new era in cancer treatment. 

Expertise 

  • Intensity Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Stereotactic Radiosurgery
  • SBRT
  • VMAT
  • Total Skin Electron Therapy (TSET)
  • Frameless Image-Guided Radiosurgery
  • PET-Guided Radiation Therapy
  • PET Scan
  • Targeted therapy
  • Immunotherapy
  • Personalized Gene-Based Therapy
  • Cancer Screening (Preventive)
  • Cytology Guided by Ultrasound

Memberships:

  • Active Member of American Association of Cancer Research (AACR).
  • Active Member of American Society of Radiation Oncology (ASTRO)
  • Founder Member of Indian Society of Neuro-Oncology (ISNO).
  • Member of Association of Radiation Oncologists of India (AROI)
  • Member of Indian Co-operative Oncology Network (ICON)

Accolades:

Awards and Recognitions

  • Meerut Ratna - 2008
  • Founder Member of Indian Society of NeuroOncology - 2010
  • Reviewer for Journal of American College of Physicians - 2015

Paper Presentation /Conferences /Workshops 

  • Research Associate for a Phase III randomized trial of stereotactic conformal radiotherapy vs conventional radiotherapy in pediatric low-grade brain tumors at Tata Memorial Hospital.
  • Conducted research on Temozolomide, concurrent and adjuvant in glioblastoma multiforme at TMH: A prospective experience.
  • Prospective study on the safety and efficacy of Temozolomide in pediatric brainstem gliomas with correlation to FDG-PET scans, presented at WFNO, Japan 2006.
  • Analyzed the palliative efficacy of Hemibody Irradiation for bony metastases in 70 patients at a single institution.
  • Investigated the role of Three Dimensional Radiotherapy in Pituitary Adenomas.
  • Contributed to the analysis of patterns of outcome of carcinoma cervix from 1996-2000.
  • Participated in a Phase II trial of 2-deoxyglucose with hypofractionated radiotherapy in glioblastoma multiforme at TMH.
  • Research Associate for a Phase III randomized trial of hyperthermia with radiotherapy vs hyperthermia alone in advanced head and neck cancer.
  • Research Associate for a Randomized Phase III trial of radiotherapy with 2-deoxyglucose vs radiotherapy alone in glioblastoma multiforme.

Top Rated Doctors

Whatsapp
Call Now